Research Paper Volume 12, Issue 5 pp 4641—4659
Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
Figure 5. WB and relative densitometric analysis for Ctr, 6-OHDA and 6-OHDA+SLAB51 for pro-BDNF, p-JNK, p-ERK1,2 and P75. Results are mean ± SE of 3 different experiments (n=3). ** p< 0.005 vs Ctr; ++ p< 0.005, +++ p< 0.0005 vs 6-OHDA. Representative WB figures are shown.